<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36232630</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Damaged DNA Is an Early Event of Neurodegeneration in Induced Pluripotent Stem Cell-Derived Motoneurons with UBQLN2<sup>P497H</sup> Mutation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11333</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms231911333</ELocationID><Abstract><AbstractText><i>Ubiquilin-2</i> (UBQLN2) mutations lead to familial amyotrophic lateral sclerosis (FALS)/and frontotemporal dementia (FTLD) through unknown mechanisms. The combination of iPSC technology and CRISPR-mediated genome editing technology can generate an iPSC-derived motor neuron (iPSC-MN) model with disease-relevant mutations, which results in increased opportunities for disease mechanism research and drug screening. In this study, we introduced a UBQLN2-P497H mutation into a healthy control iPSC line using CRISPR/Cas9, and differentiated into MNs to study the pathology of UBQLN2-related ALS. Our in vitro MN model faithfully recapitulated specific aspects of the disease, including MN apoptosis. Under sodium arsenite (SA) treatment, we found differences in the number and the size of UBQLN2<sup>+</sup> inclusions in UBQLN2<sup>P497H</sup> MNs and wild-type (WT) MNs. We also observed cytoplasmic TAR DNA-binding protein (TARDBP, also known as TDP-43) aggregates in UBQLN2<sup>P497H</sup> MNs, but not in WT MNs, as well as the recruitment of TDP-43 into stress granules (SGs) upon SA treatment. We noted that UBQLN2-P497H mutation induced MNs DNA damage, which is an early event in UBQLN2-ALS. Additionally, DNA damage led to an increase in compensation for FUS, whereas UBQLN2-P497H mutation impaired this function. Therefore, FUS may be involved in DNA damage repair signaling.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yiti</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-4245-2879</Identifier><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Baitao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Ao</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Qinyu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Mingri</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Guangnan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Miaojin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6636-6000</Identifier><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wanxi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Lingjie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Desheng</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9451-8585</Identifier><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Basic and Applied Hematology, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xionghao</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2633-7096</Identifier><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Basic and Applied Hematology, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Animal Model for Human Diseases, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mujun</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1558-1448</Identifier><AffiliationInfo><Affiliation>Hunan Key Laboratory of Basic and Applied Hematology, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Animal Model for Human Diseases, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410000, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016YFC0905100</GrantID><Agency>the National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2021zzts0565</GrantID><Agency>the Postgraduate Freedom Exploration Project of Central South University</Agency><Country/></Grant><Grant><GrantID>kq2202077</GrantID><Agency>the Natural Science Foundation of Changsha</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">FTLD</Keyword><Keyword MajorTopicYN="N">MNs</Keyword><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">axon damage</Keyword><Keyword MajorTopicYN="N">iPSCs</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36232630</ArticleId><ArticleId IdType="pmc">PMC9570184</ArticleId><ArticleId IdType="doi">10.3390/ijms231911333</ArticleId><ArticleId IdType="pii">ijms231911333</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hawrot J., Imhof S., Wainger B.J. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol. Dis. 2020;134:104680. doi: 10.1016/j.nbd.2019.104680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaus A., Sareen D. ALS patient stem cells for unveiling disease signatures of motoneuron susceptibility: Perspectives on the deadly mitochondria, ER stress and calcium triad. Front. Cell. Neurosci. 2015;9:448. doi: 10.3389/fncel.2015.00448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00448</ArticleId><ArticleId IdType="pmc">PMC4652136</ArticleId><ArticleId IdType="pubmed">26635528</ArticleId></ArticleIdList></Reference><Reference><Citation>Gois A.M., Mendon&#xe7;a D.M.F., Freire M.A.M., Santos J.R. In vitro and in vivo models of amyotrophic lateral sclerosis: An updated overview. Brain Res. Bull. 2020;159:32&#x2013;43. doi: 10.1016/j.brainresbull.2020.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2020.03.012</ArticleId><ArticleId IdType="pubmed">32247802</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial amyotrophic lateral sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L., Picher-Martel V., Codron P., Julien J.P. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol. Commun. 2019;7:103. doi: 10.1186/s40478-019-0758-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0758-7</ArticleId><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin B.C., Higgins N.R., Phung T.H., Monteiro M.J. UBQLN proteins in health and disease with a focus on UBQLN2 in ALS/FTD. FEBS J. 2021 doi: 10.1111/febs.16129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16129</ArticleId><ArticleId IdType="pmc">PMC8761781</ArticleId><ArticleId IdType="pubmed">34273246</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng G., Gu A., Niu H., Chen L., Chen Y., Zhou M., Zhang Y., Liu J., Cai L., Liang D., et al. Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1. CNS Neurosci. Ther. 2022;28:105&#x2013;115. doi: 10.1111/cns.13757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13757</ArticleId><ArticleId IdType="pmc">PMC8673703</ArticleId><ArticleId IdType="pubmed">34750982</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R., Akiyama T., Hadano S., Aoki M., Saya H., Sobue G., et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung Phuoc N., Van Broeckhoven C., van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.M., Gupta S.K., Kim K.J., Powers B.E., Cerqueira A., Wainger B.J., Ngo H.D., Rosowski K.A., Schein P.A., Ackeifi C.A., et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell. 2013;12:713&#x2013;726. doi: 10.1016/j.stem.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.04.003</ArticleId><ArticleId IdType="pmc">PMC3707511</ArticleId><ArticleId IdType="pubmed">23602540</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano H., Yasuda D., Fujimori K., Morimoto S., Takahashi S. Ropinirole, a new ALS drug candidate developed using iPSCs. Trends Pharm. Sci. 2020;41:99&#x2013;109. doi: 10.1016/j.tips.2019.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2019.12.002</ArticleId><ArticleId IdType="pubmed">31926602</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S., Rees E., Miyashita A., Costa A.R., Dodd R.B., Chan F.T., Michel C.H., et al. ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., Gunther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Martire S., Mosca L., d&#x2019;Erme M. PARP-1 involvement in neurodegeneration: A focus on Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Mech. Ageing Dev. 2015;146&#x2013;148:53&#x2013;64. doi: 10.1016/j.mad.2015.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2015.04.001</ArticleId><ArticleId IdType="pubmed">25881554</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrocola A.S., Kim S.H., Trinh A.T., Rodenkirch L.A., Tibbetts R.S. The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly (ADP-ribose) polymerase (PARP) in response to DNA damage. J. Biol. Chem. 2013;288:24731&#x2013;24741. doi: 10.1074/jbc.M113.497974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.497974</ArticleId><ArticleId IdType="pmc">PMC3750169</ArticleId><ArticleId IdType="pubmed">23833192</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.-Y., Pan L., Su S.C., Quinn E.J., Sasaki M., Jimenez J.C., Mackenzie I.R.A., Huang E.J., Tsai L.-H. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat. Neurosci. 2013;16:1383&#x2013;1391. doi: 10.1038/nn.3514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3514</ArticleId><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton S., Dernoncourt E., Delteil C., Froment C., Schiltz O., Salles B., Frit P., Calsou P. DNA damage triggers SAF-A and RNA biogenesis factors exclusion from chromatin coupled to R-loops removal. Nucleic Acids Res. 2014;42:9047&#x2013;9062. doi: 10.1093/nar/gku601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku601</ArticleId><ArticleId IdType="pmc">PMC4132723</ArticleId><ArticleId IdType="pubmed">25030905</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka A., Whelan D.R., Jamali M.S., Perri E., Shahheydari H., Toth R.P., Parakh S., Robinson T., Cheong A., Mehta P., et al. Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations. Mol. Neurodegener. 2020;15:51. doi: 10.1186/s13024-020-00386-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00386-4</ArticleId><ArticleId IdType="pmc">PMC7488163</ArticleId><ArticleId IdType="pubmed">32907630</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z.W., Chen H., Liu H.S., Lu J.F., Qian K., Huang C.L., Zhong X.F., Fan F., Zhang S.C. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun. 2015;6:9. doi: 10.1038/ncomms7626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan J.A., Hudson A.J. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Pt 2Brain. 1991;114:843&#x2013;853. doi: 10.1093/brain/114.2.843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/114.2.843</ArticleId><ArticleId IdType="pubmed">2043953</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Barschke P., Otto M. Biomarkers for diseases with TDP-43 pathology. Mol. Cell. Neurosci. 2019;97:43&#x2013;59. doi: 10.1016/j.mcn.2018.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.10.003</ArticleId><ArticleId IdType="pubmed">30399416</ArticleId></ArticleIdList></Reference><Reference><Citation>Birsa N., Bentham M.P., Fratta P. Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin. Cell Dev. Biol. 2020;99:193&#x2013;201. doi: 10.1016/j.semcdb.2019.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.023</ArticleId><ArticleId IdType="pubmed">31132467</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Konopka A., Soo K.Y., Ito D., Atkin J.D. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2017;26:2882&#x2013;2896. doi: 10.1093/hmg/ddx170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx170</ArticleId><ArticleId IdType="pubmed">28481984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J., Guerrero E.N., Hegde P.M., Liachko N.F., Wang H., Vasquez V., Gao J., Pandey A., Taylor J.P., Kraemer B.C., et al. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc. Natl. Acad. Sci. USA. 2019;116:4696&#x2013;4705. doi: 10.1073/pnas.1818415116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero E.N., Mitra J., Wang H., Rangaswamy S., Hegde P.M., Basu P., Rao K.S., Hegde M.L. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum. Mol. Genet. 2019;28:3161&#x2013;3162. doi: 10.1093/hmg/ddz141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz141</ArticleId><ArticleId IdType="pmc">PMC6867871</ArticleId><ArticleId IdType="pubmed">31504503</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998;273:5858&#x2013;5868. doi: 10.1074/jbc.273.10.5858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.10.5858</ArticleId><ArticleId IdType="pubmed">9488723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo L.J., Yang L.X. &#x3b3;-H2AX-a novel biomarker for DNA double-strand breaks. Vivo. 2008;22:305&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">18610740</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Fu K., Hodgson A., Wier E.M., Wen M.G., Kamenyeva O., Xia X., Koo L.Y., Wan F. Sam68 is required for DNA damage responses via regulating poly (ADP-ribosyl) ation. PLoS Biol. 2016;14:e1002543. doi: 10.1371/journal.pbio.1002543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002543</ArticleId><ArticleId IdType="pmc">PMC5026359</ArticleId><ArticleId IdType="pubmed">27635653</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman M., Cudkowicz M., Zinman L. Enhancing clinical trials in neurodegenerative disorders: Lessons from amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2012;25:735&#x2013;742. doi: 10.1097/WCO.0b013e32835a309d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e32835a309d</ArticleId><ArticleId IdType="pubmed">23160423</ArticleId></ArticleIdList></Reference><Reference><Citation>Poppe L., Rue L., Robberecht W., Van Den Bosch L. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS) Exp. Neurol. 2014;262:138&#x2013;151. doi: 10.1016/j.expneurol.2014.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.07.001</ArticleId><ArticleId IdType="pubmed">25017368</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S., Bruijn L.I., Chandran S., Eggan K., Ho R., Klim J.R., Livesey M.R., Lowry E., Macklis J.D., Rushton D., et al. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat. Neurosci. 2016;19:542&#x2013;553. doi: 10.1038/nn.4273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4273</ArticleId><ArticleId IdType="pmc">PMC5015775</ArticleId><ArticleId IdType="pubmed">27021939</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin K.R., Godena V.K., Hewitt V.L., Whitworth A.J. Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum. Mol. Genet. 2016;25:2378&#x2013;2392. doi: 10.1093/hmg/ddw105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw105</ArticleId><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N., Pal A., Lojewski X., Corcia P., Naujock M., Reinhardt P., Sterneckert J., Petri S., Wegner F., Storch A., et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol. Dis. 2018;115:167&#x2013;181. doi: 10.1016/j.nbd.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Naujock M., Fumagalli L., Vandoorne T., Baatsen P., Boon R., Ordovas L., Patel A., Welters M., Vanwelden T., et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 2017;8:861. doi: 10.1038/s41467-017-00911-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Gumina V., Lenzi P., Bossolasco P., Fulceri F., Volpe C., Bardelli D., Pregnolato F., Maraschi A., Fornai F., et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiol. Dis. 2020;145:105051. doi: 10.1016/j.nbd.2020.105051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105051</ArticleId><ArticleId IdType="pubmed">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Siddique T. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia. Muscle Nerve. 2012;45:157&#x2013;162. doi: 10.1002/mus.23278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23278</ArticleId><ArticleId IdType="pubmed">22246868</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., LeClerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V., Dutta K., Phaneuf D., Sobue G., Julien J.P. Ubiquilin-2 drives NF-&#x3ba;B activity and cytosolic TDP-43 aggregation in neuronal cells. Mol. Brain. 2015;8:71. doi: 10.1186/s13041-015-0162-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0162-6</ArticleId><ArticleId IdType="pmc">PMC4628361</ArticleId><ArticleId IdType="pubmed">26521126</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang B., Wu Q., Zhou H., Huang C., Xia X.G. Increased Ubqln2 expression causes neuron death in transgenic rats. J. Neurochem. 2016;139:285&#x2013;293. doi: 10.1111/jnc.13748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13748</ArticleId><ArticleId IdType="pmc">PMC5117623</ArticleId><ArticleId IdType="pubmed">27456931</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassel J.A., Reitz A.B. Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: Characterization of inhibition by nucleic acids and 4-aminoquinolines. Biochim. Biophys. Acta BBA-Proteins Proteom. 2013;1834:964&#x2013;971. doi: 10.1016/j.bbapap.2013.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2013.03.020</ArticleId><ArticleId IdType="pmc">PMC3960997</ArticleId><ArticleId IdType="pubmed">23541532</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu S., Huang J. MRN complex is an essential effector of DNA damage repair. J. Zhejiang Univ. Sci. B. 2021;22:31&#x2013;37. doi: 10.1631/jzus.B2000289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2000289</ArticleId><ArticleId IdType="pmc">PMC7818010</ArticleId><ArticleId IdType="pubmed">33448185</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein J.L., de la Torre-Ubieta L., Tian Y., Parikshak N.N., Hern&#xe1;ndez I.A., Marchetto M.C., Baker D.K., Lu D., Hinman C.R., Lowe J.K., et al. A quantitative framework to evaluate modeling of cortical development by neural stem cells. Neuron. 2014;83:69&#x2013;86. doi: 10.1016/j.neuron.2014.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.05.035</ArticleId><ArticleId IdType="pmc">PMC4277209</ArticleId><ArticleId IdType="pubmed">24991955</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Hu Z., Qiu L., Zhou T., Feng M., Hu Q., Zeng B., Li Z., Sun Q., Wu Y., et al. Seamless genetic conversion of SMN2 to SMN1 via CRISPR/Cpf1 and single-stranded oligodeoxynucleotides in spinal muscular atrophy patient-specific induced pluripotent stem cells. Hum. Gene Ther. 2018;29:1252&#x2013;1263. doi: 10.1089/hum.2017.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2017.255</ArticleId><ArticleId IdType="pubmed">29598153</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>